Lung cancer in systemic lupus erythematosus

Lung Cancer

Volumn 56, Issue 3, 2007, Pages 303-306

  Bin, J ^a   Bernatsky, S ^a   Gordon, C ^b   Boivin, J F ^c   Ginzler, E ^d   Gladman, D ^e   Fortin, P R ^e   Urowitz, M ^e   Manzi, S ^f   Isenberg, D ^g   Rahman, A ^g   Petri, M ^h   Nived, O ⁱ   Sturfeldt, G ⁱ   Ramsey Goldman, R ^j   Clarke, A E ^a,c  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c MCGILL UNIVERSITY   (Canada)

^d SUNY DOWNSTATE MEDICAL CENTER   (United States)

^e TORONTO WESTERN HOSPITAL   (Canada)

^f UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY COLLEGE LONDON   (United Kingdom)

^h JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ LUND UNIVERSITY HOSPITAL   (Sweden)

^j NORTHWESTERN UNIVERSITY   (United States)

more..

Author keywords

Lung cancer; SLE; Systemic lupus erythematosus

Indexed keywords

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER REGISTRY; CANCER RISK; CARCINOID; COHORT ANALYSIS; CONTROLLED STUDY; DATA ANALYSIS; DEMOGRAPHY; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; LARGE CELL CARCINOMA; LINKAGE ANALYSIS; LUNG ADENOCARCINOMA; LUNG ALVEOLUS CELL CARCINOMA; LUNG CANCER; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MINORITY GROUP; POPULATION; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; SMOKING; SQUAMOUS CELL CARCINOMA; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; CARCINOMA; DIAGNOSIS, DIFFERENTIAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; LUNG NEOPLASMS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; SEX DISTRIBUTION; TIME FACTORS; WORLD HEALTH;

EID: 34247574135     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2007.01.007     Document Type: Article

References (45)

1. Bernatsky S., Boivin J., Lawrence J., Rajan R., Zoma A., Manzi S., et al. An international cohort study of cancer in systemic lupus erythematosus. Arthritis Rheum 52 5 (2005) 1481-1490
2. Abu-shakra M., Gladman D.D., and Urowitz M.B. Malignancy in systemic lupus erythematosus. Arthritis Rheum 39 6 (1996) 66-71
3. Bjornadal L., Lofstrom B., Yin L., Lundberg I.E., and Ekbom A. Increased cancer incidence in a Swedish cohort of patients with systemic lupus erythematosus. Scand J Rheumatol 31 2 (2002) 66-71
4. Cibere J., Sibley J., and Haga M. Systemic lupus erythematosus and the risk of malignancy. Lupus 10 6 (2001) 394-400
5. Mellemkjaer L., Andersen V., Linet M.S., Gridley G., Hoover R., and Olsen J.H. Non-Hodgkin's lymphoma and other cancers among a cohort of patients with systemic lupus erythematosus. Arthritis Rheum 40 4 (1997) 761-768
6. Nived O., Bengsston A., Jonsen A., Sturfelt G., and Olson H. Malignancies during follow-up in an epidemiologically defined SLE inception cohort in southern Sweden. Lupus 10 7 (2001) 500-504
7. Pettersson T., Pukkala E., Teppo L., and Friman C. Increased risk of cancer in patients with systemic lupus erythematosus. Ann Rheum Dis 51 4 (1992) 437-439
8. Ramsey-Goldman R., Mattai S.A., Schilling E., Chiu Y.L., Alo C.J., and Howe H.L. Increased risk of malignancy in patients with systemic lupus erythematosus. J Invest Med 46 5 (1998) 217-222
9. Sultan S.M., Ioannou Y., and Isenberg D.A. Is there an association of malignancy with systemic lupus erythematosus?. Rheumatology 39 10 (2000) 1147-1152
10. Sweeney D.M., Manzi S., Janosky J., Selvaggi K., Ferri W., Medsger T.A., et al. Risk of malignancy in women with SLE. J Rheumatol 22 8 (1995) 1478-1482
11. Ragnarsson O., Grondal G., and Steinsson K. Risk of malignancy in an unselected cohort of Icelandic patients with systemic lupus erythematosus. Lupus 12 9 (2003) 687-691
12. Bernatsky S., Boivin J., Manzi S., Ginzler E., Gladman D.D., Urowitz M.B., et al. Mortality in systemic lupus erythematosus. Arthritis Rheum 54 8 (2006) 2550-2557
13. Ward M., and Studenski S. Clinical prognostic factors in lupus nephritis. The importance of hypertension and smoking. Arch Intern Med 152 10 (1992) 2082-2088
14. Petri M., Perez-Gutthann S., Spence D., and Hochberg M.C. Risk factors for coronary artery disease in patients with systemic lupus erythematosus. Am J Med 93 5 (1992) 513-519
15. Rahman P., Urowitz M.B., Gladman D.D., and Bruce I.N. Contribution of traditional risk factors to coronary artery disease in patients with SLE. J Rheumatol 26 11 (1999) 2363-2368
16. McAlindon T., Gianotta L., Taub N., D'Cruz D., and Hughes G. Environmental factors predicting nephritis in systemic lupus erythematosus. Ann Rheum Dis 52 10 (1993) 720-724
17. Bruce I.N., Urowitz M.B., Ibanez D., Steiner G., and Gladman D.D. The prevalence of "Framingham Risk Factors" for coronary artery disease (CAD) in women with SLE: a cohort: control study. Arthritis Rheum 48 11 (2000) 3159-3167
18. Bernatsky S., Boivin J., Joseph L., St Pierre Y., Moore A., Rajan R., et al. The prevalence of factors influencing cancer risk in lupus: social habits reproductive issues and obesity. J Rheumatol 29 12 (2002) 2551-2554
19. US Government Printing Office. Surgeon General: reducing the health consequences of smoking: 25 years of progress. Washington, 1989.
20. Pilotti S., Rilke F., Gribaudi G., et al. Sputum cytology for the diagnosis of lung cancer. Acta Cytol 26 5 (1982) 661
21. Fraire A.E. Pathology of lung cancer. Comprehensive textbook of thoracic oncology (1996), Williams and Wilkins, Baltimore p. 245
22. Linnoila R.I., and Aisner S.C. Pathology of lung cancer: an exercise in classification. In: Johnson B.E., and Johnson D.H. (Eds). Lung cancer (1995), Wiley-Liss, New York 73
23. Hammar S.D. Common neoplasms. Pulmonary pathology (1993), Springer-Verlag, New York p. 1123
24. Jarvinen P., Kaprio J., Makitalo R., et al. Systemic lupus erythematosus and related systemic diseases in a nationwide twin cohort: an increased prevalence of disease in MZ twins and concordance of disease features. J Intern Med 231 1 (1992) 67
25. Deapen D., Escalante A., Weinrib L., et al. A revised estimate of twin concordance in SLE. Arthritis Rheum 35 3 (1992) 311
26. Tsao B.P. An update on genetic studies of systemic lupus erythematosus. Curr Rheumatol Rep 4 4 (2002) 359-367
27. Harley J.B., Moser K.L., Gaffney P.M., et al. The genetics of human systemic lupus erythematosus. Curr Opin Immunol 10 6 (1998) 690
28. Kono D.H., Burlingame R.W., Owens D.G., et al. Lupus susceptibility loci in New Zealand mice. Proc Natl Acad Sci 91 21 (1994) 10168
29. Tsao B.P. Update on human systemic lupus erythematosus genetics. Curr Opin Rheumatol 16 5 (2004) 513
30. Li X., and Hemminki K. Familial multiple primary lung cancers: a population-based analysis from Sweden. Lung Cancer 47 3 (2005) 301
31. Jonsson S., Thorsteinsdottir U., Gudbjartsson D.F., et al. Familial risk of lung carcinoma in the Icelandic population. J Am Med Assoc 292 24 (2004) 2977
32. Law M.R. Genetic predisposition to lung cancer. Br J Cancer 61 2 (1990) 195
33. Amos C.I., Caporaso N.E., and Weston A. Host factors in lung cancer: a review of interdisciplinary studies. Cancer Epidemiol Biomarkers Prev 1 6 (1992) 505
34. Ooi W.L., Elston R.C., Chen V.W., et al. Increased familial risk for lung cancer. J Natl Cancer Inst 76 2 (1986) 217
35. Bromen K., Pohlabeln H., Jahn I., et al. Aggregation of lung cancer in families: results from a population-based case-control study in Germany. Am J Epidemiol 152 (2000) 497
36. Li X., and Hemminki K. Familial and second lung cancers: a nation-wide epidemiologic study from Sweden. Lung Cancer 39 3 (2003) 255
37. Samet J.M., Humble G.C., and Pathak D.R. Personal and family history of respiratory disease and lung cancer risk. Am Rev Respir Dis 134 3 (1986) 466
38. Matakidou A., Eisen T., and Houlston R.S. Systematic review of the relationship between family history and lung cancer risk. Br J Cancer 93 7 (2005) 825
39. Turner-Warwick M., Lebowitz M., Burrows B., et al. Cryptogenic fibrosing alveolitis and lung cancer. Thorax 35 (1980) 496
40. Hubbard R., Venn A., Lewis S., and Britton J. Lung cancer and cryptogenic fibrosing alveolitis. Am J Respir Crit Care Med 161 1 (2000) 5-8
41. Weidemann H.P., and Matthay R.A. Pulmonary manifestations of systemic lupus erythematosus. J Thoracic Imaging 7 2 (1992) 1
42. Weinrib L., Shamara O.P., and Quismorio F.P.J. A long-term study of interstitial lung disease in systemic lupus erythematosus. Semin Arthritis Rheum 20 1 (1990) 48
43. Gammon R.B., Bridges T.A., al-Nezir H., et al. Bronchiolitis obliterans organizing pneumonia associated with systemic lupus erythematosus. Chest 102 4 (1992) 117
44. Querat G., Barban V., Sauze N., et al. Characteristics of a novel lentivirus derived from South African sheep with pulmonary adenocarcinomatosis. Virology 158 (1987) 158
45. Brouchet L., Valmary S., Dahan M., et al. Detection of oncogenic virus genomes and gene products in lung carcinoma. Br J Cancer 92 4 (2005) 743-746